000 | 01902 a2200373 4500 | ||
---|---|---|---|
001 | 26001 | ||
003 | TR-AnTOB | ||
005 | 20240816091608.0 | ||
008 | 110201s1995 enka b 001 0 c | ||
010 | _a94009554 | ||
020 | _a052147020X (hardback) | ||
020 | _a0521576466 (pbk.) | ||
035 | _a26001 | ||
040 |
_aDNLM/DLC _cDLC _dNLM _dIAY _dUKM _dCNU _dXFF |
||
041 | _aeng | ||
043 | _an-us--- | ||
049 | _aXFFA | ||
060 |
_aW 74 _bV35 1995 |
||
090 | _aW74 .V35 1995 | ||
245 | 0 |
_aValuing health care : _bcosts, benefits, and effectiveness of pharmaceuticals and other medical technologies / _cedited by Frank A. Sloan. |
|
264 | 1 |
_aCambridge ; _aNew York : _bCambridge University Press, _c1995. |
|
300 |
_axi, 273 p. : _bill. ; _c24 cm. |
||
504 | _aBIBINDX | ||
505 | 0 | _aEvidence of effectiveness: evaluating its quality / Allan S. Detsky -- Utility assessment for estimating quality-adjusted life years / Robert M. Kaplan -- Measuring costs / David Dranove -- From cost-effectiveness ratios to resource allocation: where to draw the line? / Milton C. Weinstein -- Valuing health care benefits in money terms / Mark V. Pauly -- Discounting health effects for medical decisions / W. Kip Visusi -- Statistical issues in cost-effectiveness analyses / John Mullahy, Willard Manning -- Decision trees and Markov models in cost-effectiveness research / Emmett Keeler -- The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects / Frank A. Sloan, Christopher J. Conover. | |
650 | 0 |
_aCost-Benefit Analysis _xmethods _923081 |
|
650 | 2 |
_aHealth Services _923080 |
|
650 | 0 |
_aEconomics, Pharmaceutical _923086 |
|
650 | 2 |
_aEvaluation Studies as Topic _923079 |
|
650 | 0 |
_aOutcome and Process Assessment, Health Care _xeconomics _923078 |
|
653 | 5 | _aUnited States | |
700 |
_aSloan, Frank A. _923077 |
||
942 |
_cBK _2lcc |
||
999 |
_c26001 _d29303 |